These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2664043)
1. Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. Marolia J; Mahadevan PR Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):483-91. PubMed ID: 2664043 [TBL] [Abstract][Full Text] [Related]
2. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice. Damle A; Mahadevan PR Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062 [TBL] [Abstract][Full Text] [Related]
3. Delipidified cell components of Mycobacterium leprae and its applications. Mahadevan PR; Robinson P; Vermani M; Pardhy A; Joshi S Indian J Lepr; 1991; 63(3-4):371-87. PubMed ID: 1804891 [TBL] [Abstract][Full Text] [Related]
4. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients. Robinson P; Mahadevan PR J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
6. A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae--a possible vaccine. Marolia J; Robinson P; Mahadevan PR Clin Exp Immunol; 1990 Jan; 79(1):7-14. PubMed ID: 2154348 [TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. Kaplan G; Nathan CF; Gandhi R; Horwitz MA; Levis WR; Cohn ZA J Immunol; 1986 Aug; 137(3):983-7. PubMed ID: 3088117 [TBL] [Abstract][Full Text] [Related]
8. An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular events identified by in vitro experiments. Mahadevan PR; Robinson P Trop Med Parasitol; 1990 Sep; 41(3):310-3. PubMed ID: 2255852 [TBL] [Abstract][Full Text] [Related]
9. Human phagocytic cell responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. An in vitro comparison of leprosy vaccine components. Holzer TJ; Kizlaitis L; Vachula M; Weaver CW; Andersen BR J Immunol; 1988 Sep; 141(5):1701-8. PubMed ID: 3137262 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Mycobacterium leprae to oxygen-mediated damage. Dhople AM Microbios; 1996; 85(342):35-44. PubMed ID: 8935737 [TBL] [Abstract][Full Text] [Related]
11. The immunobiology of leprosy. Kaplan G; Cohn ZA Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911 [TBL] [Abstract][Full Text] [Related]
13. Antigenic similarity of a cultivable acid fast bacterium to Mycobacterium leprae. Joshi S; Nair SC; Mahadevan PR Indian J Med Res; 1993 Jan; 97():18-24. PubMed ID: 8486404 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide and superoxide production by peripheral blood monocytes in leprosy. Sharp AK; Banerjee DK Clin Exp Immunol; 1985 Apr; 60(1):203-6. PubMed ID: 2988833 [TBL] [Abstract][Full Text] [Related]
15. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
16. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
17. Release of reactive nitrogen intermediates from the peripheral blood-derived monocytes/macrophages of leprosy patients stimulated in vitro by tuftsin. Khare S; Bhutani LK; Rao DN Lepr Rev; 1997 Mar; 68(1):16-24. PubMed ID: 9121327 [TBL] [Abstract][Full Text] [Related]
18. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736 [TBL] [Abstract][Full Text] [Related]
19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
20. How to prevent immunological reactions in leprosy patients and interrupt transmission of Mycobacterium leprae to healthy subjects: two hypotheses. Mastrangelo G; Marcer G; Cegolon L; Buja A; Fadda E; Scoizzato L; Pavanello S Med Hypotheses; 2008 Oct; 71(4):551-63. PubMed ID: 18614293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]